Paul J Lytle - Net Worth and Insider Trading
Paul J Lytle Net Worth
The estimated net worth of Paul J Lytle is at least $89,240 dollars as of 2024-05-12. Paul J Lytle is the CFO of Avid Bioservices Inc and owns about 10,293 shares of Avid Bioservices Inc (CDMO) stock worth over $89,240. Details can be seen in Paul J Lytle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul J Lytle has not made any transactions after 2010-09-24 and currently still holds the listed stock(s).
Transaction Summary of Paul J Lytle
Paul J Lytle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul J Lytle owns 2 companies in total, including Mosaic ImmunoEngineering Inc (CPMV) , and Avid Bioservices Inc (CDMO) .
Click here to see the complete history of Paul J Lytle’s form 4 insider trades.
Insider Ownership Summary of Paul J Lytle
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CPMV | Mosaic ImmunoEngineering Inc | 2020-08-21 | director & EVP & Chief Financial Officer |
CDMO | Avid Bioservices Inc | 2010-09-24 | CFO & Corporate Secretary |
Paul J Lytle Latest Holdings Summary
Paul J Lytle currently owns a total of 1 stock. Paul J Lytle owns 10,293 shares of Avid Bioservices Inc (CDMO) as of September 24, 2010, with a value of $89,240.
Latest Holdings of Paul J Lytle
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CDMO | Avid Bioservices Inc | 2010-09-24 | 10,293 | 8.67 | 89,240 |
Holding Weightings of Paul J Lytle
Paul J Lytle Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul J Lytle has made a total of 0 transactions in Avid Bioservices Inc (CDMO) over the past 5 years. The most-recent trade in Avid Bioservices Inc is the acquisition of 955 shares on September 24, 2010, which cost Paul J Lytle around $8,957.
Insider Trading History of Paul J Lytle
- 1
Paul J Lytle Trading Performance
GuruFocus tracks the stock performance after each of Paul J Lytle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul J Lytle is 41.19%. GuruFocus also compares Paul J Lytle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul J Lytle within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul J Lytle's insider trading performs compared to the benchmark.
Performance of Paul J Lytle
Paul J Lytle Ownership Network
Ownership Network List of Paul J Lytle
Ownership Network Relation of Paul J Lytle
Paul J Lytle Owned Company Details
What does Mosaic ImmunoEngineering Inc do?
Who are the key executives at Mosaic ImmunoEngineering Inc?
Paul J Lytle is the director & EVP & Chief Financial Officer of Mosaic ImmunoEngineering Inc. Other key executives at Mosaic ImmunoEngineering Inc include 10 percent owner Case Western Reserve University , director & President and CEO Steven W King , and director & Chief Scientific Officer Nicole Franziska Steinmetz .
Mosaic ImmunoEngineering Inc (CPMV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Mosaic ImmunoEngineering Inc (CPMV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mosaic ImmunoEngineering Inc (CPMV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Mosaic ImmunoEngineering Inc (CPMV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mosaic ImmunoEngineering Inc Insider Transactions
Paul J Lytle Mailing Address
Above is the net worth, insider trading, and ownership report for Paul J Lytle. Currently GuruFocus does not have mailing address information for Paul J Lytle.